294 related articles for article (PubMed ID: 20014870)
1. Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity.
Pellicciari R; Gioiello A; Macchiarulo A; Thomas C; Rosatelli E; Natalini B; Sardella R; Pruzanski M; Roda A; Pastorini E; Schoonjans K; Auwerx J
J Med Chem; 2009 Dec; 52(24):7958-61. PubMed ID: 20014870
[TBL] [Abstract][Full Text] [Related]
2. Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies.
Sato H; Macchiarulo A; Thomas C; Gioiello A; Une M; Hofmann AF; Saladin R; Schoonjans K; Pellicciari R; Auwerx J
J Med Chem; 2008 Mar; 51(6):1831-41. PubMed ID: 18307294
[TBL] [Abstract][Full Text] [Related]
3. Nongenomic actions of bile acids. Synthesis and preliminary characterization of 23- and 6,23-alkyl-substituted bile acid derivatives as selective modulators for the G-protein coupled receptor TGR5.
Pellicciari R; Sato H; Gioiello A; Costantino G; Macchiarulo A; Sadeghpour BM; Giorgi G; Schoonjans K; Auwerx J
J Med Chem; 2007 Sep; 50(18):4265-8. PubMed ID: 17685603
[TBL] [Abstract][Full Text] [Related]
4. TGR5-mediated bile acid sensing controls glucose homeostasis.
Thomas C; Gioiello A; Noriega L; Strehle A; Oury J; Rizzo G; Macchiarulo A; Yamamoto H; Mataki C; Pruzanski M; Pellicciari R; Auwerx J; Schoonjans K
Cell Metab; 2009 Sep; 10(3):167-77. PubMed ID: 19723493
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.
Rizzo G; Passeri D; De Franco F; Ciaccioli G; Donadio L; Rizzo G; Orlandi S; Sadeghpour B; Wang XX; Jiang T; Levi M; Pruzanski M; Adorini L
Mol Pharmacol; 2010 Oct; 78(4):617-30. PubMed ID: 20631053
[TBL] [Abstract][Full Text] [Related]
6. A new life for bile acids.
Jansen PL
J Hepatol; 2010 Jun; 52(6):937-8. PubMed ID: 20392510
[TBL] [Abstract][Full Text] [Related]
7. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
[TBL] [Abstract][Full Text] [Related]
8. TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice.
Eblimit Z; Thevananther S; Karpen SJ; Taegtmeyer H; Moore DD; Adorini L; Penny DJ; Desai MS
Cardiovasc Ther; 2018 Oct; 36(5):e12462. PubMed ID: 30070769
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3-aryl-4-isoxazolecarboxamides as TGR5 receptor agonists.
Evans KA; Budzik BW; Ross SA; Wisnoski DD; Jin J; Rivero RA; Vimal M; Szewczyk GR; Jayawickreme C; Moncol DL; Rimele TJ; Armour SL; Weaver SP; Griffin RJ; Tadepalli SM; Jeune MR; Shearer TW; Chen ZB; Chen L; Anderson DL; Becherer JD; De Los Frailes M; Colilla FJ
J Med Chem; 2009 Dec; 52(24):7962-5. PubMed ID: 19902954
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological activity of potent and orally available G protein-coupled receptor 40 agonists.
Sasaki S; Kitamura S; Negoro N; Suzuki M; Tsujihata Y; Suzuki N; Santou T; Kanzaki N; Harada M; Tanaka Y; Kobayashi M; Tada N; Funami M; Tanaka T; Yamamoto Y; Fukatsu K; Yasuma T; Momose Y
J Med Chem; 2011 Mar; 54(5):1365-78. PubMed ID: 21319751
[TBL] [Abstract][Full Text] [Related]
11. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading.
Pols TW; Nomura M; Harach T; Lo Sasso G; Oosterveer MH; Thomas C; Rizzo G; Gioiello A; Adorini L; Pellicciari R; Auwerx J; Schoonjans K
Cell Metab; 2011 Dec; 14(6):747-57. PubMed ID: 22152303
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5.
Herbert MR; Siegel DL; Staszewski L; Cayanan C; Banerjee U; Dhamija S; Anderson J; Fan A; Wang L; Rix P; Shiau AK; Rao TS; Noble SA; Heyman RA; Bischoff E; Guha M; Kabakibi A; Pinkerton AB
Bioorg Med Chem Lett; 2010 Oct; 20(19):5718-21. PubMed ID: 20801037
[TBL] [Abstract][Full Text] [Related]
13. Reduction of epithelial secretion in male rat distal colonic mucosa by bile acid receptor TGR5 agonist, INT-777: role of submucosal neurons.
Duboc H; Tolstanova G; Yuan PQ; Wu V; Kaji I; Biraud M; Akiba Y; Kaunitz J; Million M; Tache Y; Larauche M
Neurogastroenterol Motil; 2016 Nov; 28(11):1663-1676. PubMed ID: 27259385
[TBL] [Abstract][Full Text] [Related]
14. TGR5: an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders.
Tiwari A; Maiti P
Drug Discov Today; 2009 May; 14(9-10):523-30. PubMed ID: 19429513
[TBL] [Abstract][Full Text] [Related]
15. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
16. Expression and function of the bile acid receptor TGR5 in Kupffer cells.
Keitel V; Donner M; Winandy S; Kubitz R; Häussinger D
Biochem Biophys Res Commun; 2008 Jul; 372(1):78-84. PubMed ID: 18468513
[TBL] [Abstract][Full Text] [Related]
17. G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes.
Wang XX; Edelstein MH; Gafter U; Qiu L; Luo Y; Dobrinskikh E; Lucia S; Adorini L; D'Agati VD; Levi J; Rosenberg A; Kopp JB; Gius DR; Saleem MA; Levi M
J Am Soc Nephrol; 2016 May; 27(5):1362-78. PubMed ID: 26424786
[TBL] [Abstract][Full Text] [Related]
18. Patented TGR5 modulators: a review (2006 - present).
Gioiello A; Rosatelli E; Nuti R; Macchiarulo A; Pellicciari R
Expert Opin Ther Pat; 2012 Dec; 22(12):1399-414. PubMed ID: 23039746
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, theoretical and structural analyses, and enantiopharmacology of 3-carboxy homologs of AMPA.
Brehm L; Greenwood JR; Sløk FA; Holm MM; Nielsen B; Geneser U; Stensbøl TB; Bräuner-Osborne H; Begtrup M; Egebjerg J; Krogsgaard-Larsen P
Chirality; 2004 Aug; 16(7):452-66. PubMed ID: 15236343
[TBL] [Abstract][Full Text] [Related]
20. The discovery of 12β-methyl-17-epi-18-nor-bile acids as potent and selective TGR5 agonists.
Luxenburger A; Harris LD; Ure EM; Jiao W; Woolhouse AD; Cameron SA; Weymouth-Wilson A; Furneaux RH; Pitman JL; Hinkley SFR
Eur J Med Chem; 2023 Mar; 250():115143. PubMed ID: 36841086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
